Likewise, CAFs derived from clinical-luminal breast cancers induced resistance to TAM by decreasing the levels of ERα when cultured with MCF7 and T47D luminal BRCA cell lines in both in vitro and in vivo experiments [34]. The gene discussed is ESR1; the disease is breast cancer.